← Leaderboards
Hengjun Chao
Mount Sinai School Of Medicine Of Nyu
$1,917,641
Attributed
$1,917,641
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $381.4K · FY2005–09$500K$375K$250K$125K$0
'05
'06
'07
'08
'09
Funding mix
By agency
NIH$1,917,641 · 2
By mechanism
R01$1,496,777 · 1
R21$420,864 · 1
Top collaborators
No co-investigators on record.
Most similar at Mount Sinai School Of Medicine Of Nyu
Same institution · by research overlap
- Yale R Nemerson$1,092,105
Others in their field
Top investigators on “Gene Therapy”
- David Heimbrook · Leidos Biomedical Research, Inc.$164,199,916
- Gregory H Reaman · National Childhood Cancer Foundation$155,841,493
- Randall J Bateman · Washington University$122,781,098
- Eric Martin McDade · Washington University$94,632,845
- Ronald G Crystal · Weill Medical College Of Cornell Univ$82,649,124
- Robert B. Diasio · University Of Alabama At Birmingham$73,470,685
Research focus
Gene TherapyPreventAffectVectorReportingProductionInnovationMuscleProgramsSerotypingGene TransferGenesBaseProteinsPhenotypeHemophilia ADependovirusLinkBase PairingGene Transduction AgentCessation Of LifeAnimal ModelEnhancer Elements (Genetics)Antigen Presenting Cell
Grant awards (6)
Gene Therapy for Muscular Dystrophy$228,971
R21 · FY2009 · NS · contact PI
Gene Therapy for Muscular Dystrophy$191,893
R21 · FY2008 · NS · contact PI
Factor IX tolerance in hemophilia gene therapy$361,613
R01 · FY2007 · HL · contact PI
FIX tolerance in hemophilia gene therapy$372,414
R01 · FY2006 · HL · contact PI
FIX tolerance in hemophilia gene therapy$381,375
R01 · FY2005 · HL
FIX tolerance in hemophilia gene therapy$381,375
R01 · FY2004 · HL